Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FSAH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,287
Award facts
- Contract value 100% obligated
- $13,287.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $13,287 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The contract, awarded on December 2, 2025, with an ultimate completion date of December 23, 2025, employs firm fixed-price pricing with no set-aside designation, indicating that DMS Pharmaceutical Group competed successfully in open federal procurement. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award contract established on November 13, 2025.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical and medical consumable supply solutions through regional prime vendor contractors. DMS Pharmaceutical Group's IDC ceiling value of approximately $500 million and performance period extending through December 2036 positions the company as a critical supplier of diverse pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals—to support military healthcare operations globally. The company's established track record of substantial federal contracting activity and demonstrated capability across multiple therapeutic categories reinforces its role as a key supplier within the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FSAH1?
SPE2DR26FSAH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FSAH1 worth?
The government has obligated $13,287 on SPE2DR26FSAH1.
Is contract SPE2DR26FSAH1 an order under another contract?
Yes. SPE2DR26FSAH1 is a delivery order under SPE2DR25D9332, an indefinite delivery contract.
Was contract SPE2DR26FSAH1 competed?
The extent of competition for SPE2DR26FSAH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award